XRAYDENTSPLY SIRONA Inc.
$8.84-31% 1Y
$8.84
$8.5352 weeks$14.68
XRAY in its own filings
XRAY's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
484
Events found in the filings · across 3,710 filings · the record starts in 1995
- Hard flags
- 3
Hard flags
- Most recent filing
- Aug 7, 2026
Most recent filing · Form 8-K/A
- Record starts
- Apr 21, 1995
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Restatement admitted (non-reliance)2 occurrences
- 2022-11-01
- Change in certifying accountantpast_3y
- 2024-03-07
- Late periodic report5 occurrences
- 2022-11-09
- Delisting notice / listing-rule failure2 occurrences
- 2022-08-15
- Material impairmenthistorical
- 2022-11-01
- SEC comment-letter activity30 occurrences
- 2023-09-29
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 7, 2026Dentsply Sirona Reports Second Quarter 2026 Results.Earnings release · press release
- Aug 6, 2026Dentsply Sirona Reports Second Quarter 2026 Results.Material event (exhibits only) · press release
- Jun 11, 2026On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”)Director or officer change · Form 8-K
- May 5, 2026Dentsply Sirona Reports First Quarter 2026 Results.Earnings release · press release
- Feb 26, 2026Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook.Earnings release · press release
- Feb 24, 2026On February 23, 2026, upon the recommendation of the Corporate Governance and Nominating Committee (the “Governance Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”), and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from …Director or officer change · Form 8-K
- Jan 13, 2026On January 10, 2026, upon the recommendation of the Corporate Governance and Nominating Committee (the “Governance Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”), and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 10 …Director or officer change · Form 8-K
- Dec 31, 2025On December 24, 2025, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Second Amendment to Credit …Material agreement entered · Form 8-K
- Nov 25, 2025On November 25, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced the appointment of Michael Pomeroy as the Company’s interim Chief Financial Officer, who will serve in this temporary capacity until the Company identifies and appoints a permanent Chief Financial Officer.Other event · Form 8-K
- Nov 7, 2025On November 6, 2025, DENTSPLY SIRONA Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) reporting that the Company had determined that Matthew E. Garth will no longer serve as the Executive Vice President and Chief Financial Officer of the Company effective November 5, 2025 (the …Director or officer change · Form 8-K/A
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Instruments & Supplies
Ranks #16 of 21 by RyuScore